1-(4-溴丁氧基)-2-溴苯 | 105212-11-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 1-(4-溴丁氧基)-2-溴苯
• 英文名称: 1-bromo-2-(4-bromobutoxy)benzene
• CAS: 105212-11-1
• 化学式: C₁₀H₁₂Br₂O
• 分子量: 308.013
• InChiKey: DTQMNVGKPXPAFP-UHFFFAOYSA-N

物化性质

• 稳定性/保质期：

  遵照规定使用和储存，则不会发生分解。

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xn
• 安全说明：
  S37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2909309090

SDS

Name:	1-(4-Bromobutoxy)-2-bromobenzene 95% Material Safety Data Sheet
Synonym:
CAS:	105212-11-1

Section 1 - Chemical Product MSDS Name:1-(4-Bromobutoxy)-2-bromobenzene 95% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
105212-11-1	1-(4-Bromobutoxy)-2-bromobenzene	95%	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 105212-11-1: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: Not available.
Odor: stench
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: >200 deg C
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H12Br2O
Molecular Weight: 308.01

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, hydrogen bromide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 105212-11-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(4-Bromobutoxy)-2-bromobenzene - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 105212-11-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 105212-11-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 105212-11-1 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-(4-溴丁氧基)-2-溴苯 在 sodium perborate 、 锰 、 NiBr2*diglyme 、 2,6-二（1-吡唑基）吡啶 、 sodium iodide 作用下， 以 N,N-二甲基乙酰胺 为溶剂， 反应 12.0h， 生成 C₁₆H₂₅BrO₂
  参考文献：
  名称：

  镍催化的三组分烯烃还原性二碳官能化反应以得到烷基硼酸盐

  摘要：

  我们报告了用于构建烷基硼酸酯的三组分烯烃还原性双碳官能化，特别是镍催化的硼酸乙烯酯与各种烷基溴化物和芳基碘化物的还原性二烷基化和烷基芳基化。该反应显示出良好的偶联效率和出色的官能团相容性，可方便地进行复杂天然产物和药物分子的后期修饰。结合烷基硼酸酯转化，该反应还可以在复杂化合物的模块化和聚合合成中找到应用。

  DOI：

  10.1039/d0sc02054k
• 作为产物：
  描述：

  4-溴-1-丁醇 、 2-溴苯酚 在 三苯基膦 、 偶氮二甲酸二乙酯 作用下， 以 四氢呋喃 为溶剂， 以51.9%的产率得到1-(4-溴丁氧基)-2-溴苯
  参考文献：
  名称：

  发现哌啶醇衍生物可用于组合治疗耐偶氮念珠菌的念珠菌病

  摘要：

  需要有效的策略来应对由耐药真菌引起的侵袭性真菌感染。以前，我们根据氟哌啶醇的药物用途设计了一系列抗真菌苯并环烷衍生物。本文中，进行了进一步的结构优化和抗真菌机理研究，从而发现了具有改进的协同抗真菌效力，选择性和水溶性的新哌啶醇衍生物B2。特别地，化合物B2和氟康唑的组合显示出对耐唑的白色念珠菌的有效的体外和体内抗真菌活性。化合物B2通过调节与毒力相关的基因来抑制重要的毒力因子，并通过下调CYP51编码基因和外排泵基因来提高氟康唑的疗效。综上所述，哌啶醇衍生物B2代表了一种有前途的铅化合物，可用于抗唑类念珠菌病的联合治疗。

  DOI：

  10.1021/acsinfecdis.0c00849

文献信息

• Nickel-Catalyzed Sonogashira Reactions of Non-activated Secondary Alkyl Bromides and Iodides
  作者：Jun Yi、Xi Lu、Yan-Yan Sun、Bin Xiao、Lei Liu

  DOI：10.1002/anie.201307069

  日期：2013.11.18

  A nicked reaction: The title reaction of terminal alkynes with non‐activated secondary alkyl iodides and bromides was accomplished for the first time. This reaction provides a new and practical approach for the synthesis of substituted alkynes (see scheme; cod=cyclo‐1,5‐octadiene).

  昵称反应：首次完成末端炔与未活化的仲烷基碘和溴化物的标题反应。该反应为合成取代炔烃提供了一种新的实用方法（见方案； cod = cyclo-1,5-辛二烯）。
• Synthesis of Large Ring Macrocycles (12–18) by Recyclable Palladium-Complexed Dendrimers on Silica Gel Catalyzed Intramolecular Cyclocarbonylation Reactions
  作者：Shui-Ming Lu、Howard Alper

  DOI：10.1002/chem.200601724

  日期：2007.7.6

  Intramolecular cyclocarbonylation reactions with palladium-complexed dendrimers on silica gel as catalysts are very effective for the synthesis of twelve- to eighteen-membered ring macrocycles. This process can tolerate a wide variety of functional groups, including halide, ether, ketone, and ester. The heterogeneous dendritic catalysts facilitate excellent substrate reactivity, affording oxygen-,

  用钯络合物的树枝状大分子在硅胶上作为催化剂的分子内环羰基化反应对于合成十二至十八元环大环非常有效。该过程可以耐受多种官能团，包括卤化物，醚，酮和酯。非均相树枝状催化剂促进了优异的底物反应性，以70-92％的收率提供了含氧，氮或硫的三环杂环。重要的是，这些系统很容易通过简单的过滤就可以回收，并且可以重复使用几次，而只损失很少的活性。
• A Practical Procedure for Iron-Catalyzed Cross-Coupling Reactions of Sterically Hindered Aryl-Grignard Reagents with Primary Alkyl Halides
  作者：Chang-Liang Sun、Helga Krause、Alois Fürstner

  DOI：10.1002/adsc.201301089

  日期：2014.4.14

  Although iron‐catalyzed cross‐coupling reactions of arylmagnesium halides with alkyl halides are well established and proceed effectively under a variety of experimental conditions, they often find limitations when working with sterically hindered aryl‐Grignard reagents. Outlined in this paper is a practical solution that allows this gap in coverage to be filled. Specifically, it is shown that bis

  尽管已经建立了芳基卤化镁与烷基卤化物的铁催化交叉偶联反应，并且可以在各种实验条件下有效地进行，但在使用位阻芳基格氏试剂时，它们经常会发现局限性。本文概述的是一种实用的解决方案，可以弥补覆盖范围中的这一空白。具体地，表明双（二乙基膦基）乙烷（depe）对Fe（+2）产生了有效的配位环境。这种可商购的配体足够纤细，即使邻位，邻位也不会干扰铁中心的负载-二取代的芳基卤化镁，但能够防止所得的有机铁物质过早还原偶联，这似乎也不是碱性的。该反应与各种极性官能团以及含有β-杂原子取代基的底物兼容。而且，该方法甚至允许包埋的新戊基亲电子试剂与溴化间苯二甲酸镁一样大，而供体芳基化，而仲烷基卤化物趋于消除。
• 苯并脂（肪）环衍生物及其用途
  申请人：华东理工大学

  公开号：CN109384707B

  公开（公告）日：2021-12-17

  本发明一种苯并脂(肪)环衍生物及其用途。所述苯并脂(肪)环衍生物由含氮杂环基的取代基取代的苯并脂(肪)环类化合物得到。本发明提供的取代的苯并脂(肪)环类化合物中绝大部分具有抑制真菌活性，且部分化合物的抑制真菌活性优于现有抗真菌药物。此外，本发明提供的部分取代的苯并脂(肪)环类化合物与现有抗真菌药物联用，对耐药真菌表现出良好的协同抑制作用。因此，本发明为新颖抗真菌药物或抗真菌药物的增效剂的研制奠定坚实的基础。
• Breaking the <i>tert</i>-Butyllithium Contact Ion Pair: A Gateway to Alternate Selectivity in Lithiation Reactions
  作者：Michael P. Crockett、Jeanette Piña、Achyut Ranjan Gogoi、Remy F. Lalisse、Andrew V. Nguyen、Osvaldo Gutierrez、Andy A. Thomas

  DOI：10.1021/jacs.2c13047

  日期：2023.5.17

  by NMR and DFT methods. It was determined that hexamethylphosphoramide (HMPA) can shift the equilibrium of t-BuLi to include the triple ion pair (t-Bu–Li–t-Bu)−/HMPA4Li+ which serves as a reservoir for the highly reactive separated ion pair t-Bu–/HMPA4Li+. Because the Li-atom’s valences are saturated in this ion pair, the Lewis acidity is significantly decreased; in turn, the basicity is maximized

  通过NMR和DFT方法详细研究了路易斯碱性磷酰胺对叔丁基锂聚集结构的影响。据确定，六甲基磷酰胺 (HMPA) 可以改变t- BuLi 的平衡，以包含三重离子对 ( t -Bu–Li– t -Bu) - /HMPA 4 Li + ，它充当高反应性分离离子的储存库对t -Bu – /HMPA 4 Li + 。由于该离子对中锂原子的价态已饱和，路易斯酸度显着降低；反过来，碱度被最大化，这使得氧杂环内的典型定向效应被覆盖，并且远程 sp 3 C-H 键被去质子化。此外，利用这些新获得的锂聚集态开发了一种简单的γ-锂化和苯并二氢吡喃杂环与各种烷基卤化物亲电子试剂的捕获方案，收率良好。